Adequan Canine Injection for Dogs 100 mg/mL Single 5 mL Vial
|This product requires a prescription|
Adequan Canine (polysulfated glycosaminoglycan) is the only FDA-approved disease-modifying osteoarthritis drug (DMOAD) that inhibits cartilage loss in the dog's joints, and may help to:
- Restore joint lubrication
- Relieve inflammation
- Renew the building blocks of healthy cartilage
That’s what makes Adequan Canine different from a supplement or NSAID. It proactively treats the disease and not just the signs of canine osteoarthritis.
This product requires a prescription.
Indications and Usage: Adequan Canine is recommended for intramuscular injection for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints.
Contraindications: Do not use in dogs showing hypersensitivity to PSGAG. PSGAG is a synthetic heparinoid; do not use in dogs with known or suspected bleeding disorders.
Precautions: The safe use of Adequan Canine used in breeding, pregnant, or lactating dogs has not been evaluated. Use with caution in dogs with renal or hepatic impairment.
Polysulfated Glycosaminoglycan Solution 100 mg/mL in a 5 mL preserved Multiple dose vial for intramuscular use in dogs
Use Adequan Canine early, at the first clinical signs of OA before it progresses, and cartilage is irreversibly damaged.
Administer twice weekly for up to 4 weeks (maximum of 8 injections) at approved dosage of 2 mg/lb body weight (0.02 mL/lb or 1 mL/50 lb) by intramuscular (IM) injection only. Do not exceed the recommended dose or therapeutic regimen. Do not mix Adequan Canine with other drugs or solvents. Use within 28 days of first puncture and puncture a maximum of 10 times.
You may see signs of improvement within one month.